表紙
市場調查報告書

生技藥品外包的全球市場:考察、趨勢、預測

Global Biologics Outsourcing Market: Insights, Trends & Forecast (2019-2023)

出版商 Koncept Analytics 商品編碼 914439
出版日期 內容資訊 英文 105 Pages
訂單完成後即時交付
價格
Back to Top
生技藥品外包的全球市場:考察、趨勢、預測 Global Biologics Outsourcing Market: Insights, Trends & Forecast (2019-2023)
出版日期: 2019年10月21日內容資訊: 英文 105 Pages
簡介

本報告提供全球生技藥品外包的市場相關分析,整體市場規模趨勢預測 (過去、今後5年份) ,及各類型及各地區詳細趨勢,市場背景情況 (製藥產業全體/生技藥品產業整體趨勢),主要的推動及阻礙市場要素,企業間的競爭狀態、業績比較,主要企業簡介等調查。

第1章 市場概要

第2章 全球醫藥品市場

  • 全球醫藥品市場 (以金額為準)
  • 全球醫藥品市場 (預測值,以金額為準)
  • 全球醫藥品市場:各領域
    • 小分子市場
    • 學名藥市場
    • OTC (成藥) 市場
    • 生物相似藥市場
      • 市場規模 (成果值、預測值,以金額為準)
  • 第3章 全球生技藥品市場
  • 全球生技藥品市場 (以金額為準)
  • 全球生技藥品市場 (預測值,以金額為準)
  • 全球生技藥品市場:各領域
    • 單株抗體 (mAb)
      • 市場規模 (成果值、預測值,以金額為準)
  • 全球生技藥品市場:各地區
  • 全球生技藥品市場成長率:各地區

第4章 全球生技藥品外包市場

  • 全球生技藥品外包市場 (以金額為準)
  • 全球生技藥品外包市場 (預測值,以金額為準)
  • 全球生技藥品外包市場:各類型
    • 檢驗設備
    • 試劑、套件
      • 市場規模 (成果值、預測值,以金額為準)
  • 全球生技藥品外包市場:各地區
  • 全球生技藥品外包市場成長率:各地區

第5章 中國的生技藥品/生技藥品外包市場

  • 中國的生技藥品市場 (以金額為準)
  • 中國的生技藥品市場 (預測值,以金額為準)
  • 中國的生技藥品市場:各領域
    • 單株抗體 (mAb)
      • 市場規模 (成果值、預測值,以金額為準)
  • 中國的生技藥品外包市場 (以金額為準)
  • 中國的生技藥品外包市場 (預測值,以金額為準)

第6章 市場動態

  • 成長促進因素
  • 主要趨勢和動靜
  • 課題

第7章 競爭環境

  • 全球市場
    • 市場收益額、股票市值比較
    • Wuxi Biologics:全球生技藥品外包市場佔有率
    • 全球市場佔有率:各企業
  • 中國市場
    • 國內市場佔有率:各企業

第8章 企業簡介

  • Lonza Group AG
    • 產業概要
    • 主要的財務指標
    • 事業策略
  • Wuxi Biologics
  • Boehringer Ingelheim
  • Catalent Inc.
  • Abzena Limited
  • Thermo Fisher
目錄

The global biologics outsourcing market is estimated to reach US$26.4 billion in 2023, growing at a CAGR of 16.77% for the period spanning from 2019 to 2023. The factors such as increasing aging population, higher healthcare spending, rising incidences of chronic conditions, increasing R&D spending on biologics drugs and growing focus on biologics are expected to drive the market. However, growth of the industry will be challenged by high capital requirement, high technical requirement, regulatory issues and ability to capture customers from established competitors. A few notable trends include new drug development and increasing demand for antibody conjugates.

The global biologics outsourcing market is broadly segmented into two types which are instruments and kits & reagents. The use of antibodies for treating various chronic diseases such as asthma and diabetes is increasing investment in research activities which has stimulated the demand for biologics outsourcing market globally.

The fastest growing regional market is China owing to the Chinese government which has issued many regulations and policies to support the development of the biologics outsourcing market in China. Marketing Authorization Holder or MAH, Pilot Program for drug approval process allows biologics applicants with products that are manufactured in China to outsource the manufacturing process to third party biologics outsourcing service providers. The U.S. and Asia are highly established premium markets that contribute to significant shares in the global market.

Scope of the report:

The report provides a comprehensive analysis of the global biologics outsourcing market, segmented into two types which are instruments and kits & reagents.

The major regional markets have been analyzed, with the coverage of China.

The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

The competitive landscape of the market, along with the company profiles of leading players (Lonza Group, Wuxi Biologics, Boehringer Inhgelheim, Catalent Inc., Abzena and Thermo Fisher) are also presented in detail.

Key Target Audience:

  • Pharmaceutical Biotech Manufacturers
  • Individual Researchers
  • CROs/CDMOs/CMOs
  • Academic Institutes
  • Investment Banks
  • Government Bodies & Regulating Authorities

Table of Contents

1. Market Overview

  • 1.1 Pharmaceutical Industry
  • 1.2 Biologics
  • 1.3 Manufacturing Process of Biologics
  • 1.4 Medical Uses for Biologics
  • 1.5 Products of Biologics
  • 1.6 Biologics Outsourcing

2. Global Pharmaceutical Market

  • 2.1 Global Pharmaceutical Market by Value
  • 2.2 Global Pharmaceutical Market Forecast by Value
  • 2.3 Global Pharmaceutical Market by Segment
    • 2.3.1 Global Small Molecule Market by Value
    • 2.3.2 Global Small Molecule Forecast Market by Value
    • 2.3.3 Global Generics Market by Value
    • 2.3.4 Global Generics Market Forecast by Value
    • 2.3.5 Global OTC Market by Value
    • 2.3.6 Global OTC Market Forecast by Value
    • 2.3.7 Global Biosimilar Market by Value
    • 2.3.8 Global Biosimilar Market Forecast by Value

3. Global Biologics Market

  • 3.1 Global Biologics Market by Value
  • 3.2 Global Biologics Market Forecast by Value
  • 3.3 Global Biologics Market by Segment
    • 3.3.1 Global mAb Market by Value
    • 3.3.2 Global mAb Market Forecast by Value
  • 3.4 Global Biologics Market by Region
  • 3.5 Global Biologics Market Growth by Region

4. Global Biologics Outsourcing Market

  • 4.1 Global Biologics Outsourcing Market by Value
  • 4.2 Global Biologics Outsourcing Market Forecast by Value
  • 4.3 Global Biologics Outsourcing Market by Type
    • 4.3.1 Global Biologics Outsourcing Instrument Market by Value
    • 4.3.2 Global Biologics Outsourcing Kits & Reagents Market Forecast by Value
  • 4.4 Global Biologics Outsourcing Market Growth by Region

5. China Biologics/Biologics Outsourcing Market

  • 5.1 China Biologics Market by Value
  • 5.2 China Biologics Market Forecast by Value
  • 5.3 China Biologics Market by Segment
    • 5.3.1 China mAb Market by Value
    • 5.3.2 China mAb Market Forecast by Value
  • 5.4 China Biologics Outsourcing Market by Value
  • 5.5 China Biologics Outsourcing Market Forecast by Value

6. Market Dynamics

  • 6.1 Growth Drivers
    • 6.1.1 Rising Ageing Population
    • 6.1.2 Rising Incidences of Chronic Conditions
    • 6.1.3 Escalating Healthcare Spending
    • 6.1.4 Accelerating Economy
    • 6.1.5 Growing Focus on Biologics
  • 6.2 Key Trends & Developments
    • 6.2.1 Increasing Spending on Biologics Drugs
    • 6.2.2 New Drug Development
    • 6.2.3 Increasing Demand for Antibody Conjugates
  • 6.3 Challenges
    • 6.3.1 High Capital Requirement
    • 6.3.2 High Technical Requirement
    • 6.3.3 Stringent Regulations
    • 6.3.4 Ability to Capture Customers from Established Competitors

7. Competitive Landscape

  • 7.1 Global Market
    • 7.1.1 Revenue and Market Cap Comparison
    • 7.1.2 Wuxi Biologics' Share in Global Biologics Outsourcing Market
    • 7.1.3 Global Biologics Outsourcing Market Share by Company
  • 7.2 China
    • 7.2.1 China Biologics Outsourcing Market Share by Company

8. Company Profiles

  • 8.1 Lonza Group AG
    • 8.1.1 Business Overview
    • 8.1.2 Financial Overview
    • 8.1.3 Business Strategies
  • 8.2 Wuxi Biologics
    • 8.2.1 Business Overview
    • 8.2.2 Financial Overview
    • 8.2.3 Business Strategies
  • 8.3 Boehringer Ingelheim
    • 8.3.1 Business Overview
    • 8.3.2 Financial Overview
    • 8.3.3 Business Strategies
  • 8.4 Catalent Inc.
    • 8.4.1 Business Overview
    • 8.4.2 Financial Overview
    • 8.4.3 Business Strategies
  • 8.5 Abzena Limited
    • 8.5.1 Business Overview
    • 8.5.2 Financial Overview
    • 8.5.3 Business Strategies
  • 8.6 Thermo Fisher
    • 8.6.1 Business Overview
    • 8.6.2 Financial Overview
    • 8.6.3 Business Strategies

List of Figures

  • Segmentation of Pharmaceutical Industry
  • Biologics Value Chain
  • Manufacturing Process of Biologics
  • Products/Segments of Biologics
  • Global Pharmaceutical Market by Value (2014-2018)
  • Global Pharmaceutical Market Forecast by Value (2019-2023)
  • Global Pharmaceutical Market by Segment (2018)
  • Global Small Molecule Market by Value (2014-2018)
  • Global Small Molecule Forecast Market by Value (2019-2023)
  • Global Generics Market by Value (2014-2018)
  • Global Generics Market Forecast by Value (2019-2023)
  • Global OTC Market by Value (2014-2018)
  • Global OTC Market Forecast by Value (2019-2023)
  • Global Biosimilar Market by Value (2014-2018)
  • Global Biosimilar Market Forecast by Value (2019-2023)
  • Global Biologics Market by Value (2014-2018)
  • Global Biologics Market Forecast by Value (2019-2023)
  • Global Biologics Market by Segment (2018)
  • Global mAb Market by Value (2014-2018)
  • Global mAb Market Forecast by Value (2019-2023)
  • Global Biologics Market by Region (2018)
  • Global Biologics Market Growth by Region (2018-2023)
  • Global Biologics Outsourcing Market by Value (2014-2018)
  • Global Biologics Outsourcing Market Forecast by Value (2019-2023)
  • Global Biologics Outsourcing Market by Type (2018)
  • Global Biologics Outsourcing Instrument Market by Value (2018-2023)
  • Global Biologics Outsourcing Kits & Reagents Market Forecast by Value (2018-2023)
  • Global Biologics Outsourcing Market Growth by Region (2018-2023)
  • China Biologics Market by Value (2014-2018)
  • China Biologics Market Forecast by Value (2019-2023)
  • China mAb Market by Value (2014-2018)
  • China mAb Market Forecast by Value (2019-2023)
  • China Biologics Outsourcing Market by Value (2014-2018)
  • China Biologics Outsourcing Market Forecast by Value (2019-2023)
  • Global Population Above 65 Years (2014-2018)
  • The U.S. Prevalence of Chronic Diseases (2010-2030)
  • Global Healthcare Spending Per Capita (2014-2018)
  • Global GDP Per Capita (2014-2018)
  • Global Spending on Biologics Drugs (2014-2018)
  • Drug Discovery Market (2016/2025)
  • Wuxi Biologics' Share in Global Biologics Outsourcing Market (2018-2023)
  • Global Biologics Outsourcing Market Share by Company (2018)
  • China Biologics Outsourcing Market Share by Company (2018)
  • Lonza Group Sales by Segments (2018)
  • Lonza Group Sales by Geographic Regions (2018)
  • Lonza Group Sales and Profit (2014-2018)
  • Wuxi Biologics Revenue by Region (2018)
  • Wuxi Biologics Revenue and Net Profit (2014-2018)
  • Boehringer Ingelheim Sales by Product Category (2018)
  • Boehringer Ingelheim Sales by Region (2018)
  • Boehringer Ingelheim Net Sales and Net Income (2014-2018)
  • Catalent Inc. Revenue by Segment (2018)
  • Catalent Inc. Revenue by Region (2018)
  • Catalent Inc. Net Revenue and Net Earnings (2014-2018)
  • Abzena Revenue by Segment (2018)
  • Abzena Revenue by Region (2018)
  • Abzena Revenue and Loss (2015-2018)
  • Thermo Fisher Revenue by Segment (2018)
  • Thermo Fisher Revenue by Region (2018)
  • Thermo Fisher Revenue and Net Income (2014-2018)

List of Tables

  • Key Players - Revenue & Market Cap Comparison (2018)
  • Catalent Inc. Segments and Their Offerings & Services (2018)
Back to Top